MASIMO CORPORATION

Lobbying for MASIMO CORPORATION

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $110,000.00 expenses · posted Jul 17, 2025

Lobbying activity 2

Health Issues

Support of legislation to mandate continuous monitoring for patients taking opioids; Patient safety policy and legislation; Remote patient monitoring technology and telehealth Medicare coverage

Tariff (miscellaneous tariff bills)

Issues related to increased tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.